메뉴 건너뛰기




Volumn 15, Issue 2, 2012, Pages 305-316

A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors

Author keywords

Angiomotin; Antibodies; Chemotherapy; DNA vaccination; Vessel permeability

Indexed keywords

ANGIOMOTIN; ANGIOMOTIN VACCINE; DNA VACCINE; DOXORUBICIN; EPITOPE; TUMOR ANTIGEN; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; AMOT PROTEIN, MOUSE; CANCER VACCINE; SIGNAL PEPTIDE;

EID: 84865144668     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-012-9263-3     Document Type: Article
Times cited : (37)

References (42)
  • 1
    • 34548283459 scopus 로고    scopus 로고
    • Are oncoantigens suitable targets for anti-tumour therapy?
    • DOI 10.1038/nrc2208, PII NRC2208
    • Cavallo F, Calogero RA, Forni G (2007) Are oncoantigens suitable targets for anti-tumour therapy? Nat Rev Cancer 7(9):707-713. doi:10.1038/nrc2208 (Pubitemid 47327413)
    • (2007) Nature Reviews Cancer , vol.7 , Issue.9 , pp. 707-713
    • Cavallo, F.1    Calogero, R.A.2    Forni, G.3
  • 4
    • 33646786773 scopus 로고    scopus 로고
    • Vaccination for treatment and prevention of cancer in animal models
    • DOI 10.1016/S0065-2776(06)90005-4, PII S0065277606900054
    • Cavallo F, Offringa R, van der Burg SH, Forni G, Melief CJ (2006) Vaccination for treatment and prevention of cancer in animal models. Adv Immunol 90:175-213. doi:10.1016/S0065-2776(06)90005-4 (Pubitemid 43765801)
    • (2006) Advances in Immunology , vol.90 , pp. 175-213
    • Cavallo, F.1    Offringa, R.2    Van Der Burg, S.H.3    Forni, G.4    Melief, C.J.M.5
  • 5
    • 44949166624 scopus 로고    scopus 로고
    • The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination
    • DOI 10.1038/nm1769, PII NM1769
    • Chiarle R, Martinengo C, Mastini C, Ambrogio C, D'Escamard V, Forni G, Inghirami G (2008) The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination. Nat Med 14(6):676-680. doi:10.1038/nm1769 (Pubitemid 351809545)
    • (2008) Nature Medicine , vol.14 , Issue.6 , pp. 676-680
    • Chiarle, R.1    Martinengo, C.2    Mastini, C.3    Ambrogio, C.4    D'Escamard, V.5    Forni, G.6    Inghirami, G.7
  • 6
    • 0037303197 scopus 로고    scopus 로고
    • Cancer immunoprevention: Tracking down persistent tumor antigens
    • DOI 10.1016/S1471-4906(02)00030-3, PII S1471490602000303
    • Lollini PL, Forni G (2003) Cancer immunoprevention: tracking down persistent tumor antigens. Trends Immunol 24(2):62-66. doi:S1471490602000303 (Pubitemid 36120640)
    • (2003) Trends in Immunology , vol.24 , Issue.2 , pp. 62-66
    • Lollini, P.-L.1    Forni, G.2
  • 7
    • 33644534148 scopus 로고    scopus 로고
    • Vaccines for tumour prevention
    • DOI 10.1038/nrc1815, PII N1815
    • Lollini PL, Cavallo F, Nanni P, Forni G (2006) Vaccines for tumour prevention. Nat Rev Cancer 6(3):204-216. doi:10.1038/nrc1815 (Pubitemid 43292564)
    • (2006) Nature Reviews Cancer , vol.6 , Issue.3 , pp. 204-216
    • Lollini, P.-L.1    Cavallo, F.2    Nanni, P.3    Forni, G.4
  • 9
    • 0030576517 scopus 로고    scopus 로고
    • Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
    • DOI 10.1016/S0092-8674(00)80108-7
    • Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86(3):353-364. doi:S0092-8674(00) 80108-710 (Pubitemid 26272076)
    • (1996) Cell , vol.86 , Issue.3 , pp. 353-364
    • Hanahan, D.1    Folkman, J.2
  • 10
    • 0028951043 scopus 로고
    • Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
    • Holmgren L, O'Reilly MS, Folkman J (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1(2):149-153
    • (1995) Nat Med , vol.1 , Issue.2 , pp. 149-153
    • Holmgren, L.1    O'reilly, M.S.2    Folkman, J.3
  • 11
    • 0035911953 scopus 로고    scopus 로고
    • Angiomotin: An angiostatin binding protein that regulates endothelial cell migration and tube formation
    • DOI 10.1083/jcb.152.6.1247
    • Troyanovsky B, Levchenko T, Mansson G, Matvijenko O, Holmgren L (2001) Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol 152(6):1247-1254 (Pubitemid 34280181)
    • (2001) Journal of Cell Biology , vol.152 , Issue.6 , pp. 1247-1254
    • Troyanovsky, B.1    Levchenko, T.2    Mansson, G.3    Matvijenko, O.4    Holmgren, L.5
  • 12
    • 0037130937 scopus 로고    scopus 로고
    • Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains
    • DOI 10.1016/S0378-1119(02)00928-9, PII S0378111902009289
    • Bratt A, Wilson WJ, Troyanovsky B, Aase K, Kessler R, Van Meir EG, Holmgren L (2002) Angiomotin belongs to a novel protein family with conserved coiled-coil and PDZ binding domains. Gene 298(1):69-77. doi:S0378111902009289 (Pubitemid 35284264)
    • (2002) Gene , vol.298 , Issue.1 , pp. 69-77
    • Bratt, A.1    Wilson, W.J.2    Troyanovsky, B.3    Aase, K.4    Kessler, R.5    Meir, E.G.V.6    Holmgren, L.7
  • 13
    • 1442332677 scopus 로고    scopus 로고
    • Angiomotin expression promotes hemangioendothelioma invasion
    • DOI 10.1038/sj.onc.1207264
    • Levchenko T, Bratt A, Arbiser JL, Holmgren L (2004) Angiomotin expression promotes hemangioendothelioma invasion. Oncogene 23(7):1469-1473. doi:10.1038/sj.onc.1207264 (Pubitemid 38406842)
    • (2004) Oncogene , vol.23 , Issue.7 , pp. 1469-1473
    • Levchenko, T.1    Bratt, A.2    Arbiser, J.L.3    Holmgren, L.4
  • 14
    • 39149088327 scopus 로고    scopus 로고
    • Differential roles of p80-and p130-angiomotin in the switch between migration and stabilization of endothelial cells
    • doi:10.1016/j.bbamcr.2007.11.018
    • Ernkvist M, Birot O, Sinha I, Veitonmaki N, Nystrom S, Aase K, Holmgren L (2008) Differential roles of p80-and p130-angiomotin in the switch between migration and stabilization of endothelial cells. Biochim Biophys Acta 1783(3):429-437. doi:10.1016/j.bbamcr.2007.11.018
    • (2008) Biochim Biophys Acta , vol.1783 , Issue.3 , pp. 429-437
    • Ernkvist, M.1    Birot, O.2    Sinha, I.3    Veitonmaki, N.4    Nystrom, S.5    Aase, K.6    Holmgren, L.7
  • 18
    • 0036337222 scopus 로고    scopus 로고
    • Preclinical profile and clinical potential of gadocoletic acid trisodium salt (B22956/1), a new intravascular contrast medium for MRI
    • DOI 10.1016/S1076-6332(03)80273-8
    • Cavagna FM, Lorusso V, Anelli PL, Maggioni F, de Haen C (2002) Preclinical profile and clinical potential of gadocoletic acid trisodium salt (B22956/1), a new intravascular contrast medium for MRI. Acad Radiol 9(Suppl 2):S491-S494 (Pubitemid 34857764)
    • (2002) Academic Radiology , vol.9 , Issue.SUPPL. 2
    • Cavagna, F.M.1    Lorusso, V.2    Anelli, P.L.3    Maggioni, F.4    De Haen, C.5
  • 21
    • 0035300530 scopus 로고    scopus 로고
    • A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia
    • Cifaldi L, Quaglino E, Di Carlo E, Musiani P, Spadaro M, Lollini PL, Wolf S, Boggio K, Forni G, Cavallo F (2001) A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. Cancer Res 61(7):2809-2812 (Pubitemid 32691915)
    • (2001) Cancer Research , vol.61 , Issue.7 , pp. 2809-2812
    • Cifaldi, L.1    Quaglino, E.2    Di Carlo, E.3    Musiani, P.4    Spadaro, M.5    Lollini, P.L.6    Wolf, S.7    Boggio, K.8    Forni, G.9    Cavallo, F.10
  • 22
    • 77953438206 scopus 로고    scopus 로고
    • Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent lowavidity T cells: Potential and limits of its therapeutic efficacy
    • doi:10.4049/jimmunol.0901215
    • Rolla S, Ria F, Occhipinti S, Di Sante G, Iezzi M, Spadaro M, Nicolo C, Ambrosino E, Merighi IF, Musiani P, Forni G, Cavallo F (2010) Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent lowavidity T cells: potential and limits of its therapeutic efficacy. J Immunol 184(11):6124-6132. doi:10.4049/jimmunol.0901215
    • (2010) J Immunol , vol.184 , Issue.11 , pp. 6124-6132
    • Rolla, S.1    Ria, F.2    Occhipinti, S.3    Di Sante, G.4    Iezzi, M.5    Spadaro, M.6    Nicolo, C.7    Ambrosino, E.8    Merighi, I.F.9    Musiani, P.10    Forni, G.11    Cavallo, F.12
  • 23
    • 0142244181 scopus 로고    scopus 로고
    • Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases
    • Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, Pollard JW (2003) Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 163(5):2113-2126. doi:10.1016/S0002-9440(10)63568-7 (Pubitemid 37310040)
    • (2003) American Journal of Pathology , vol.163 , Issue.5 , pp. 2113-2126
    • Lin, E.Y.1    Jones, J.G.2    Li, P.3    Zhu, L.4    Whitney, K.D.5    Muller, W.J.6    Pollard, J.W.7
  • 24
    • 77954538586 scopus 로고    scopus 로고
    • An autoimmune-mediated strategy for prophylactic breast cancer vaccination
    • doi: 10.1038/nm.2161
    • Jaini R, Kesaraju P, Johnson JM, Altuntas CZ, Jane-Wit D, Tuohy VK (2010) An autoimmune-mediated strategy for prophylactic breast cancer vaccination. Nat Med 16(7):799-803. doi: 10.1038/nm.2161
    • (2010) Nat Med , vol.16 , Issue.7 , pp. 799-803
    • Jaini, R.1    Kesaraju, P.2    Johnson, J.M.3    Altuntas, C.Z.4    Jane-Wit, D.5    Tuohy, V.K.6
  • 25
    • 40449140821 scopus 로고    scopus 로고
    • Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-gamma receptors
    • doi:180/1/26126
    • Ding JW, Zhou T, Zeng H, Ma L, Verbeek JS, Yin D, Shen J, Chong AS (2008) Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-gamma receptors. J Immunol 180(1):261-268. doi:180/1/26126
    • (2008) J Immunol , vol.180 , Issue.1 , pp. 261-268
    • Ding, J.W.1    Zhou, T.2    Zeng, H.3    Ma, L.4    Verbeek, J.S.5    Yin, D.6    Shen, J.7    Chong, A.S.8
  • 26
  • 28
    • 52049120831 scopus 로고    scopus 로고
    • ErbB2 transgenic mice: A tool for investigation of the immune prevention and treatment of mammary carcinomas
    • Chapter 20:Unit 20 29 21- 20 29-10 doi:10.1002/0471142735.im2009s82
    • Quaglino E, Mastini C, Forni G, Cavallo F (2008) ErbB2 transgenic mice: a tool for investigation of the immune prevention and treatment of mammary carcinomas. Curr Protoc Immunol Chapter 20:Unit 20 29 21-20 29-10. doi:10.1002/0471142735.im2009s82
    • (2008) Curr Protoc Immunol
    • Quaglino, E.1    Mastini, C.2    Forni, G.3    Cavallo, F.4
  • 30
    • 44249087196 scopus 로고    scopus 로고
    • Anti-angiogenic active immunotherapy: A new approach to cancer treatment
    • doi:10.1007/s00262-008-0452-2
    • Pan J, Jin P, Yan J, Kabelitz D (2008) Anti-angiogenic active immunotherapy: a new approach to cancer treatment. Cancer Immunol Immunother 57(8):1105-1114. doi:10.1007/s00262-008-0452-2
    • (2008) Cancer Immunol Immunother , vol.57 , Issue.8 , pp. 1105-1114
    • Pan, J.1    Jin, P.2    Yan, J.3    Kabelitz, D.4
  • 31
    • 33644603226 scopus 로고    scopus 로고
    • Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer
    • doi:10.1186/1471-2407-6-16
    • Jiang WG, Watkins G, Douglas-Jones A, Holmgren L, Mansel RE (2006) Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer. BMC Cancer 6:16. doi:10.1186/1471-2407-6-16
    • (2006) BMC Cancer , vol.6 , pp. 16
    • Jiang, W.G.1    Watkins, G.2    Douglas-Jones, A.3    Holmgren, L.4    Mansel, R.E.5
  • 33
    • 33745963117 scopus 로고    scopus 로고
    • Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker
    • DOI 10.1200/JCO.2006.06.8080
    • Hylton N (2006) Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 24(20):3293-3298. doi:10.1200/JCO.2006.06. 8080 (Pubitemid 46622069)
    • (2006) Journal of Clinical Oncology , vol.24 , Issue.20 , pp. 3293-3298
    • Hylton, N.1
  • 34
    • 53749092242 scopus 로고    scopus 로고
    • Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma
    • doi:10.1200/JCO.2007.15.5655
    • Hahn OM, Yang C, Medved M, Karczmar G, Kistner E, Karrison T, Manchen E, Mitchell M, Ratain MJ, Stadler WM (2008) Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma. J Clin Oncol 26(28):4572-4578. doi:10.1200/JCO.2007.15.5655
    • (2008) J Clin Oncol , vol.26 , Issue.28 , pp. 4572-4578
    • Hahn, O.M.1    Yang, C.2    Medved, M.3    Karczmar, G.4    Kistner, E.5    Karrison, T.6    Manchen, E.7    Mitchell, M.8    Ratain, M.J.9    Stadler, W.M.10
  • 35
    • 23844524757 scopus 로고    scopus 로고
    • Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma
    • DOI 10.1158/1078-0432.CCR-04-2655
    • Marzola P, Degrassi A, Calderan L, Farace P, Nicolato E, Crescimanno C, Sandri M, Giusti A, Pesenti E, Terron A, Sbarbati A, Osculati F (2005) Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma. Clin Cancer Res 11(16):5827-5832. doi:10.1158/1078-0432.CCR-04-2655 (Pubitemid 41170309)
    • (2005) Clinical Cancer Research , vol.11 , Issue.16 , pp. 5827-5832
    • Marzola, P.1    Degrassi, A.2    Calderan, L.3    Farace, P.4    Nicolato, E.5    Crescimanno, C.6    Sandri, M.7    Giusti, A.8    Pesenti, E.9    Terron, A.10    Sbarbati, A.11    Osculati, F.12
  • 36
    • 83155178515 scopus 로고    scopus 로고
    • MRI of cells and mice at 1 and 7 Tesla with Gd-targeting agents: When the low field is better!
    • doi:10.1002/cmmi.436
    • Geninatti-Crich S, Szabo I, Alberti D, Longo D, Aime S (2011) MRI of cells and mice at 1 and 7 Tesla with Gd-targeting agents: when the low field is better! Contrast Media Mol Imaging 6(6):421-425. doi:10.1002/cmmi.436
    • (2011) Contrast Media Mol Imaging , vol.6 , Issue.6 , pp. 421-425
    • Geninatti-Crich, S.1    Szabo, I.2    Alberti, D.3    Longo, D.4    Aime, S.5
  • 37
    • 77955661133 scopus 로고    scopus 로고
    • Visualizing vascular permeability and lymphatic drainage using labeled serum albumin
    • doi:10.1007/s10456-010-9170-4
    • Vandoorne K, Addadi Y, Neeman M (2010) Visualizing vascular permeability and lymphatic drainage using labeled serum albumin. Angiogenesis 13(2):75-85. doi:10.1007/s10456-010-9170-4
    • (2010) Angiogenesis , vol.13 , Issue.2 , pp. 75-85
    • Vandoorne, K.1    Addadi, Y.2    Neeman, M.3
  • 38
    • 77952785340 scopus 로고    scopus 로고
    • Attenuation of PI3K/Akt-mediated tumorigenic signals through PTEN activation by DNA vaccine-induced anti-ErbB2 antibodies
    • doi:10.4049/jimmunol.0903375
    • Porzia A, Lanzardo S, Citti A, Cavallo F, Forni G, Santoni A, Galandrini R, Paolini R (2010) Attenuation of PI3K/Akt-mediated tumorigenic signals through PTEN activation by DNA vaccine-induced anti-ErbB2 antibodies. J Immunol 184(8): 4170-4177. doi:10.4049/jimmunol.0903375
    • (2010) J Immunol , vol.184 , Issue.8 , pp. 4170-4177
    • Porzia, A.1    Lanzardo, S.2    Citti, A.3    Cavallo, F.4    Forni, G.5    Santoni, A.6    Galandrini, R.7    Paolini, R.8
  • 40
    • 0043245914 scopus 로고    scopus 로고
    • Synergy between tumor immunotherapy and antiangiogenic therapy
    • DOI 10.1182/blood-2002-12-3738
    • Nair S, Boczkowski D, Moeller B, Dewhirst M, Vieweg J, Gilboa E (2003) Synergy between tumor immunotherapy and antiangiogenic therapy. Blood 102(3):964-971. doi:10.1182/blood-2002-12-3738 (Pubitemid 36917791)
    • (2003) Blood , vol.102 , Issue.3 , pp. 964-971
    • Nair, S.1    Boczkowski, D.2    Moeller, B.3    Dewhirst, M.4    Vieweg, J.5    Gilboa, E.6
  • 41
    • 70350655979 scopus 로고    scopus 로고
    • VEGF as an inhibitor of tumor vessel maturation: Implications for cancer therapy
    • doi:10.1517/14712590903208883
    • Greenberg JI, Cheresh DA (2009) VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy. Expert Opin Biol Ther 9(11):1347-1356. doi:10.1517/14712590903208883
    • (2009) Expert Opin Biol Ther , vol.9 , Issue.11 , pp. 1347-1356
    • Greenberg, J.I.1    Cheresh, D.A.2
  • 42
    • 79960096827 scopus 로고    scopus 로고
    • Normalization of the vasculature for treatment of cancer and other diseases
    • doi: 10.1152/physrev.00038.2010
    • Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK (2011) Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 91(3):1071-1121. doi: 10.1152/physrev.00038.2010
    • (2011) Physiol Rev , vol.91 , Issue.3 , pp. 1071-1121
    • Goel, S.1    Duda, D.G.2    Xu, L.3    Munn, L.L.4    Boucher, Y.5    Fukumura, D.6    Jain, R.K.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.